Buckingham Strategic Wealth’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$500K Buy
4,604
+44
+1% +$5.19K 0.01% 466
2024
Q1
$602K Buy
4,560
+134
+3% +$16.7K 0.01% 423
2023
Q4
$539K Sell
4,426
-66
-1% -$7.36K 0.01% 422
2023
Q3
$504K Buy
4,492
+83
+2% +$10.5K 0.01% 416
2023
Q2
$642K Buy
4,409
+270
+7% +$36.7K 0.01% 370
2023
Q1
$528K Hold
4,139
0.01% 366
2022
Q4
$528K Sell
4,139
-121
-3% -$14K 0.01% 368
2022
Q3
$445K Buy
4,260
+244
+6% +$26.8K 0.01% 391
2022
Q2
$422K Buy
4,016
+958
+31% +$114K 0.01% 405
2022
Q1
$391K Sell
3,058
-7
-0.2% -$844 0.01% 415
2021
Q4
$378K Sell
3,065
-44
-1% -$5.76K 0.01% 418
2021
Q3
$442K Buy
3,109
+29
+0.9% +$4.27K 0.01% 378
2021
Q2
$481K Buy
3,080
+292
+10% +$47.3K 0.01% 372
2021
Q1
$433K Sell
2,788
-231
-8% -$35.8K 0.02% 357
2020
Q4
$452K Buy
3,019
+453
+18% +$64K 0.02% 335
2020
Q3
$339K Sell
2,566
-14
-0.5% -$1.83K 0.03% 339
2020
Q2
$299K Buy
+2,580
New +$297K 0.03% 317
2020
Q1
Sell
-1,399
Closed -$203K 524
2019
Q4
$203K Buy
+1,399
New +$193K 0.02% 439

Other funds holding ZBH

Buckingham Strategic Wealth's ZBH Position: Q2 2024 in Review

Buckingham Strategic Wealth increased its Zimmer Biomet (ZBH) stake by 0.96% in Q2 2024, buying an estimated $5.19K and bringing the position to 4,604 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #466.

Buckingham Strategic Wealth first reported a position in ZBH in Q4 2019 and has held it in 18 quarters since. The position peaked at $642K in Q2 2023. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Buckingham Strategic Wealth held 4,604 shares of Zimmer Biomet worth $500K as of Q2 2024.
  • Buckingham Strategic Wealth bought 44 Zimmer Biomet shares in Q2 2024, an estimated $5.19K.
  • Zimmer Biomet made up 0.01% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #466 holding.
  • Buckingham Strategic Wealth first reported a position in Zimmer Biomet in Q4 2019 and has held it in 18 quarters since.
  • Buckingham Strategic Wealth's Zimmer Biomet position peaked at $642K in Q2 2023.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.